The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
https://thehill.com/policy/healthcare/5118031-fda-approves-new-type-of-non-opioid-pain-medication/

